TY  - GEN
AU  - Fujimoto,Ayumi
AU  - Hiramoto,Nobuhiro
AU  - Yamasaki,Satoshi
AU  - Inamoto,Yoshihiro
AU  - Ogata,Masao
AU  - Sugio,Yasuhiro
AU  - Fukuda,Takahiro
AU  - Uchida,Naoyuki
AU  - Ikegame,Kazuhiro
AU  - Matsuoka,Ken-Ichi
AU  - Shiratori,Souichi
AU  - Kondo,Tadakazu
AU  - Miyamoto,Toshihiro
AU  - Eto,Tetsuya
AU  - Ichinohe,Tatsuo
AU  - Kanda,Yoshinobu
AU  - Atsuta,Yoshiko
AU  - Suzuki,Ritsuro
TI  - Low incidence of posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab
SN  - 1099-1069
PY  - 2020///0417
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents, Immunological
KW  - therapeutic use
KW  - Combined Modality Therapy
KW  - Female
KW  - Follow-Up Studies
KW  - Hematopoietic Stem Cell Transplantation
KW  - methods
KW  - Humans
KW  - Incidence
KW  - Japan
KW  - epidemiology
KW  - Lymphoma, B-Cell
KW  - pathology
KW  - Lymphoproliferative Disorders
KW  - Male
KW  - Middle Aged
KW  - Prognosis
KW  - Retrospective Studies
KW  - Rituximab
KW  - Survival Rate
KW  - Transplantation, Homologous
KW  - Young Adult
N1  - Publication Type: Journal Article; Multicenter Study
UR  - https://doi.org/10.1002/hon.2714
ER  -